FDA Inspection 786869 — Novartis Pharma AG
The FDA completed an inspection of Novartis Pharma AG on Jun 8, 2012 in Basel. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 8, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Basel (Switzerland)
Additional details
Sponsor, Contract Research Organization